Sanofi Pasteur Inc. drugs
5 results
Beyfortus (nirsevimab)
(nirsevimab)Sanofi Pasteur Inc.
Usage: BEYFORTUS is indicated for preventing Respiratory Syncytial Virus (RSV) lower respiratory tract disease in neonates and infants during their first RSV season and in children up to 24 months at risk of severe RSV disease through their second RSV season.
Flublok trivalent northern hemisphere (influenza a virus a/west virginia/30/2022 (h1n1) recombinant hemagglutinin antigen, influenza a virus a/massachusetts/18/2022 (h3n2) recombinant hemagglutinin antigen, and influenza b virus b/austria/1359417/2021 recombinant hemagglutinin antigen)
(INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/MASSACHUSETTS/18/2022 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN)Sanofi Pasteur Inc.
Usage: Flublok is a vaccine indicated for active immunization against influenza A virus subtypes and influenza type B virus. It is approved for use in individuals aged 18 years and older to prevent influenza-related diseases.
Fluzone hd quadrivalent southern hemisphere (influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/croatia/10136rv/2023 x-425a (h3n2) antigen (formaldehyde inactivated), influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated), andinfluenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated))
(INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), andINFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED))Sanofi Pasteur Inc.
Usage: Fluzone® High-Dose Quadrivalent Southern Hemisphere is a vaccine for active immunization against influenza A and B viruses, specifically indicated for individuals 65 years and older.
Fluzone hd tiv sh 2025 (influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/croatia/10136rv/2023 x-425a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated))
(INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED))Sanofi Pasteur Inc.
Usage: Fluzone® High-Dose Southern Hemisphere is a vaccine for active immunization against influenza A and B viruses. It is specifically approved for individuals 65 years and older to help prevent influenza-related disease.
Fluzone trivalent southern hemisphere (influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/croatia/10136rv/2023 x-425a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated))
(INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED))Sanofi Pasteur Inc.
Usage: Fluzone® Southern Hemisphere is a vaccine for active immunization against influenza A subtype viruses and type B virus. It is approved for individuals 6 months and older.